Published in Br J Haematol on November 01, 2007
Evolving treatment strategies for myeloma. Br J Cancer (2005) 1.04
Histological regression of amyloid in AL amyloidosis is exclusively seen after normalization of serum free light chain. Haematologica (2009) 0.89
The impact of novel therapeutic agents before and after frontline autologous stem cell transplantation in patients with multiple myeloma. Blood Res (2013) 0.81
Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple Myeloma. Adv Hematol (2014) 0.81
Review of thalidomide in the treatment of newly diagnosed multiple myeloma. Ther Clin Risk Manag (2007) 0.78
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial. Lancet (2010) 5.04
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. JAMA (2002) 4.94
Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival. J Clin Oncol (2005) 4.27
The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc (2012) 3.45
Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol (2004) 2.91
Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol (2005) 2.62
Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML). Blood (2012) 2.39
Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Clin Oncol (R Coll Radiol) (2004) 2.35
Guidelines for the diagnosis and management of multiple myeloma 2011. Br J Haematol (2011) 2.14
Burkitt's lymphoma. Lancet (2012) 2.02
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet (2013) 1.85
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol (2005) 1.83
Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma. J Bone Miner Res (2009) 1.72
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial. Lancet Oncol (2011) 1.71
Time course of the interaction between tadalafil and nitrates. J Am Coll Cardiol (2003) 1.71
Contribution of problem drug users' deaths to excess mortality in Scotland: secondary analysis of cohort study. BMJ (2008) 1.69
Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetes. Am Heart J (2012) 1.65
Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. Diabetes Care (2011) 1.60
Quality of life, self-esteem, fatigue, and sexual function in young men after cancer: a controlled cross-sectional study. Cancer (2010) 1.59
Evaluating the PRASE patient safety intervention - a multi-centre, cluster trial with a qualitative process evaluation: study protocol for a randomised controlled trial. Trials (2014) 1.56
Evidence based medicine inevitably increases testosterone prescribing. BMJ (2012) 1.54
Side effects of analgesia may significantly reduce quality of life in symptomatic multiple myeloma: a cross-sectional prevalence study. Support Care Cancer (2014) 1.53
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation. Blood (2011) 1.50
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping. Blood (2008) 1.45
Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trial. Leuk Lymphoma (2012) 1.44
Diagnosis and management of acute graft-versus-host disease. Br J Haematol (2012) 1.43
Summary of the recommendations on sexual dysfunctions in men. J Sex Med (2010) 1.42
Less than half of patients aged 65 years or under with myeloma proceed to transplantation: results of a two region population-based survey. Br J Haematol (2005) 1.41
Giving up smoking. Hosp Med (2004) 1.39
Believe-it then PROVE-IT. Int J Clin Pract (2004) 1.39
CEMO in a UK stallion. Vet Rec (2002) 1.39
Regional heterogeneity of cellular prion protein isoforms in the mouse brain. Brain (2003) 1.37
Evidence evaluation: a response to the court of appeal judgment in R v T. Sci Justice (2011) 1.30
Interpreting small quantities of DNA: the hierarchy of propositions and the use of Bayesian networks. J Forensic Sci (2002) 1.20
Suicide trends and geographical variations in the United Kingdom, 1991-2004. Health Stat Q (2006) 1.19
Therapeutic potential of an anti-CD79b antibody-drug conjugate, anti-CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma. Blood (2009) 1.19
CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(-)CD8(-)alphabetaTCR(+) Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden. Br J Haematol (2008) 1.17
Immunological and autoimmune considerations of Autism Spectrum Disorders. J Autoimmun (2013) 1.17
Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men. J Urol (2004) 1.16
Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium. Am J Hematol (2014) 1.15
Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL. Blood (2013) 1.14
Trends and geographical variations in alcohol-related deaths in the United Kingdom, 1991-2004. Health Stat Q (2007) 1.12
Therapeutic action of citrate in urolithiasis explained by chemical speciation: increase in pH is the determinant factor. Nephrol Dial Transplant (2005) 1.11
Relation of erectile dysfunction to angiographic coronary artery disease. Am J Cardiol (2003) 1.10
Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: secondary outcomes of a randomised controlled trial. Eur J Cancer (2010) 1.09
Allogeneic stem cell transplantation for myelofibrosis in 2012. Br J Haematol (2012) 1.08
Management of cytomegalovirus infection in haemopoietic stem cell transplantation. Br J Haematol (2013) 1.06
In vitro generation of long-lived human plasma cells. J Immunol (2012) 1.04
Efficacy of monotherapy compared with combined antianginal drugs in the treatment of chronic stable angina pectoris: a meta-analysis. Coron Artery Dis (2002) 1.03
Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia. Blood (2002) 1.03
Rituximab plus chlorambucil as first-line treatment for chronic lymphocytic leukemia: Final analysis of an open-label phase II study. J Clin Oncol (2014) 0.99
Living with advanced but stable multiple myeloma: a study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of life. J Pain Symptom Manage (2013) 0.98
Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk. J Urol (2013) 0.97
Attention-deficit hyperactivity disorder across the lifespan. Br J Psychiatry (2013) 0.97
Erectile dysfunction in the cardiovascular patient. Eur Heart J (2013) 0.96
Prognostic factors in renal cell carcinoma: association of preoperative sodium concentration with survival. Clin Cancer Res (2008) 0.96
Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process. Cytometry B Clin Cytom (2006) 0.95
DCDT2980S, an anti-CD22-monomethyl auristatin E antibody-drug conjugate, is a potential treatment for non-Hodgkin lymphoma. Mol Cancer Ther (2013) 0.94
International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24. Qual Life Res (2013) 0.93
Patients' experience of chronic lymphocytic leukaemia: baseline health-related quality of life results from the LRF CLL4 trial. Br J Haematol (2008) 0.92
A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia. Br J Haematol (2011) 0.92
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol (2005) 0.91
High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: short-term efficacy correlates with reduction of macroscopic and histologic synovitis. Arthritis Rheum (2002) 0.90
Counting the dead and what they died of. Bull World Health Organ (2006) 0.90
Organ-specific management and supportive care in chronic graft-versus-host disease. Br J Haematol (2012) 0.90
Changes in the human mitochondrial genome after treatment of malignant disease. Mutat Res (2003) 0.90
Diagnosis and management of chronic graft-versus-host disease. Br J Haematol (2012) 0.90
A functional variant in the core promoter of the CD95 cell death receptor gene predicts prognosis in acute promyelocytic leukemia. Blood (2011) 0.89
A randomised controlled trial of cognitive behaviour therapy vs treatment as usual in the treatment of mild to moderate late life depression. Int J Geriatr Psychiatry (2008) 0.89
Which health-related quality of life aspects are important to patients with chronic myeloid leukemia receiving targeted therapies and to health care professionals? GIMEMA and EORTC Quality of Life Group. Ann Hematol (2012) 0.88
Aspirin acetylates nitric oxide synthase type 3 in platelets thereby increasing its activity. Cardiovasc Res (2009) 0.87
B-cell chronic lymphocytic leukaemia cells show specific changes in membrane protein expression during different stages of cell cycle. Br J Haematol (2007) 0.86
Resolution of methotrexate-induced Epstein-Barr virus-associated mucocutaneous ulcer. Br J Haematol (2014) 0.86
Coronary and systemic hemodynamic effects of sildenafil citrate: from basic science to clinical studies in patients with cardiovascular disease. Int J Cardiol (2002) 0.86
FcRL5 as a target of antibody-drug conjugates for the treatment of multiple myeloma. Mol Cancer Ther (2012) 0.86
Erectile dysfunction and cardiac disease: recommendations of the Second Princeton Conference. Curr Urol Rep (2006) 0.86
Erectile dysfunction: a marker of silent coronary artery disease. Eur Heart J (2006) 0.85
Painful leg ulceration: a prospective, longitudinal cohort study. Wound Repair Regen (2007) 0.85
Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing. Am J Cardiol (2006) 0.85
Aspirin modifies nitric oxide synthase activity in platelets: effects of acute versus chronic aspirin treatment. Cardiovasc Res (2003) 0.85
Simulating calcium salt precipitation in the nephron using chemical speciation. Urol Res (2011) 0.85
Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming. Transplantation (2009) 0.84
Is MRD eradication a desirable goal in CLL? Best Pract Res Clin Haematol (2010) 0.84
Two natural pregnancies following allogeneic transplantation for Fanconi anaemia. Br J Haematol (2007) 0.84
Prognostic significance of interleukin-7 receptor-α gene polymorphisms in allogeneic stem-cell transplantation: a confirmatory study. Transplantation (2011) 0.83
Defining the role of renal transplantation in the modern management of multiple myeloma and other plasma cell dyscrasias. Nephron Clin Pract (2012) 0.83
Pharmacotherapy for erectile dysfunction. J Sex Med (2004) 0.83
Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review. J Antimicrob Chemother (2013) 0.82
A polymorphism in the 3' UTR of IRF4 linked to susceptibility and pathogenesis in chronic lymphocytic leukaemia and Hodgkin lymphoma has limited impact in multiple myeloma. Br J Haematol (2010) 0.82
Phosphodiesterase type 5 inhibitors improve endothelial function and may benefit cardiovascular conditions. Am J Med (2013) 0.82
The metabolic syndrome and erectile dysfunction: multiple vascular risk factors and hypogonadism. Eur Urol (2006) 0.81
Cardiovascular risk factors determine erectile and arterial function response to sildenafil. Am J Hypertens (2006) 0.81
Intravascular large B-cell lymphoma associated with a near-tetraploid karyotype, rearrangement of BCL6, and a t(11;14)(q13;q32). Cancer Genet Cytogenet (2006) 0.81
Asymmetric dimethyl arginine levels correlate with cardiovascular risk factors in patients with erectile dysfunction. Atherosclerosis (2005) 0.80
Epstein-Barr virus-independent diffuse large B-cell lymphoma in DNA ligase 4 deficiency. J Allergy Clin Immunol (2012) 0.80